{"product_id":"sbra-vrio-analysis","title":"Sabra Health Care REIT, Inc. (SBRA): VRIO Analysis [Mar-2026 Updated]","description":"\u003cbr\u003e\u003cp\u003eIs Sabra Health Care REIT, Inc. (SBRA)'s success built on fleeting trends or truly sustainable competitive advantage? This VRIO analysis distills the core of its strategy, rigorously testing its key resources for Value, Rarity, Inimitability, and Organization. Dive in now to uncover the definitive verdict on what truly sets Sabra Health Care REIT, Inc. (SBRA) apart - or leaves it vulnerable.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eSabra Health Care REIT, Inc. (SBRA) - VRIO Analysis: 1. Investment-Grade Balance Sheet \u0026amp; Capital Access\n\u003c\/h2\u003e\n\u003cp\u003eYou're looking at Sabra Health Care REIT, Inc.'s (SBRA) ability to access cheap capital, which is the lifeblood of any REIT. This isn't just about having money; it's about having the \u003cstrong\u003ebest\u003c\/strong\u003e money when you need to buy properties. The recent rating upgrade is the clearest signal of this strength.\u003c\/p\u003e\n\u003cp\u003eThe takeaway here is that SBRA's disciplined financial management has translated into a structural cost-of-capital advantage that competitors will struggle to match in this market. This advantage directly flows to the bottom line by boosting the expected return on every new acquisition.\u003c\/p\u003e\n\u003cp\u003eHere’s the quick math on the VRIO dimensions for this core financial resource:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eVRIO Dimension\u003c\/td\u003e\n\u003ctd\u003eAssessment \u0026amp; Key Data (2025 Fiscal Year)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eValue\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAllows for a lower cost of capital for acquisitions and refinancing. Moody's upgraded the issuer rating to \u003cstrong\u003eBaa3\u003c\/strong\u003e on September 10, 2025, validating this discipline.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eRarity\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAchieving a \u003cstrong\u003eBaa3\u003c\/strong\u003e rating in the current tight rate environment is rare and signals superior financial management compared to peers.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eImitability\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eDifficult to copy overnight; it requires years of disciplined leverage management, evidenced by keeping Net Debt to Adjusted EBITDA at \u003cstrong\u003e4.96x\u003c\/strong\u003e as of September 30, 2025.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eOrganization\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eThe finance team is clearly organized to exploit this, shown by securing a new five-year, \u003cstrong\u003e$500 million\u003c\/strong\u003e term loan in July 2025 at an effective rate of \u003cstrong\u003e4.64%\u003c\/strong\u003e.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cstrong\u003eCompetitive Advantage\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSustained. Low-cost capital access is a structural advantage in a capital-intensive business like healthcare real estate.\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe Value component is clear: lower borrowing costs mean higher returns on invested capital. When SBRA refinanced \u003cstrong\u003e$500 million\u003c\/strong\u003e in debt in July 2025, they locked in an effective interest rate of about \u003cstrong\u003e4.64%\u003c\/strong\u003e, pushing out maturities to 2030. That’s smart money management.\u003c\/p\u003e\n\u003cp\u003eWhat this estimate hides is the ongoing operational discipline required to maintain the rating. If leverage creeps up, the rating drops, and the advantage vanishes. The current ratio of \u003cstrong\u003e4.96x\u003c\/strong\u003e Net Debt to Adjusted EBITDA as of Q3 2025 is the proof point of that control.\u003c\/p\u003e\n\u003cp\u003eYou can see the organization in action through their recent capital structure moves:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eRating upgrade to \u003cstrong\u003eBaa3\u003c\/strong\u003e in September 2025.\u003c\/li\u003e\n\u003cli\u003eNet Debt\/Adjusted EBITDA at \u003cstrong\u003e4.96x\u003c\/strong\u003e (Q3 2025).\u003c\/li\u003e\n\u003cli\u003eSecured \u003cstrong\u003e$500 million\u003c\/strong\u003e term loan (July 2025).\u003c\/li\u003e\n\u003cli\u003eCost of permanent debt was \u003cstrong\u003e3.94%\u003c\/strong\u003e year-to-date.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eStill, this advantage is only sustained if the organization keeps its focus. If onboarding new assets causes leverage to spike above 5.5x, the competitive edge erodes fast. The organization must keep the Net Debt\/EBITDA ratio tight.\u003c\/p\u003e\n\u003cp\u003eFinance: Review the covenant compliance certificate for the new term loan by end of day Wednesday.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eSabra Health Care REIT, Inc. (SBRA) - VRIO Analysis: 2. Managed Senior Housing (SHOP) Operational Expertise\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Directly drives higher cash flow growth than typical triple-net leases. Same-store managed senior housing Cash Net Operating Income (NOI) jumped \u003cstrong\u003e13.3%\u003c\/strong\u003e year-over-year in Q3 2025.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Many REITs avoid the operational complexity; Sabra’s ability to drive double-digit NOI growth here is not common.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Moderately difficult; it requires deep, on-the-ground knowledge of operator management, which Sabra claims stems from its operational background.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e The company is actively organizing to exploit this by targeting a 40% run-rate for the SHOP portfolio, updated from a previous 30% target.\u003c\/p\u003e\n\u003cp\u003eThe current structure and performance metrics supporting this expertise include:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eValue\u003c\/td\u003e\n\u003ctd\u003ePeriod\/Context\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSame Store Managed SHOP Cash NOI Growth\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e13.3%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eYear-over-year in Q3 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEx-Holiday Transition Same Store SHOP Cash NOI Growth\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e15.9%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eYear-over-year in Q3 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSHOP Portfolio Contribution to Annualized Cash NOI\u003c\/td\u003e\n\u003ctd\u003eNearly \u003cstrong\u003e26%\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eAs of Q3 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet Debt to Adjusted EBITDA\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e4.96x\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAs of September 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMoody's Senior Unsecured Notes Rating\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003eBaa3\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eUpgraded in September 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe portfolio composition and strategic targets reflect this organizational focus:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTotal Properties: \u003cstrong\u003e363\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eSenior Housing – Managed Properties: \u003cstrong\u003e83\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eQ3 2025 Normalized FFO per diluted common share: \u003cstrong\u003e$0.36\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003eQ3 2025 Normalized AFFO per diluted common share: \u003cstrong\u003e$0.38\u003c\/strong\u003e\n\u003c\/li\u003e\n\u003cli\u003e2025 Investment Target Exceeded: More than \u003cstrong\u003e$500 million\u003c\/strong\u003e closed plus awarded deals year-to-date through Q3 2025.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary to Sustained. The high growth rate is a current advantage, but sustained by management's focus on this segment.\u003c\/p\u003e\n\n\u003cbr\u003e\u003ch2\u003eSabra Health Care REIT, Inc. (SBRA) - VRIO Analysis: 3. Strategic Operator Relationship Model\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Reduces risk by partnering with nimble, local\/regional operators rather than relying on a few massive tenants.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Most peers focus on larger, national operators; Sabra’s focus on smaller, regional partners is a distinct strategy, supported by 59 relationships across 399 investments as of March 31, 2025.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Moderately difficult; it requires a specific, relationship-driven sourcing and due diligence process that takes time to build, leveraging management’s over 100 years of combined operating experience.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e They maintain a low maximum relationship concentration of \u003cstrong\u003e0.4%\u003c\/strong\u003e, updated as of 09.30.2025, showing the organization is structured to enforce this diversification.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary.\u003c\/p\u003e\n\u003cp\u003eThe operator relationship model supports a diversified portfolio structure, as detailed below:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eAsset Class\u003c\/th\u003e\n\u003cth\u003eProperty Count (as of 09.30.2025)\u003c\/th\u003e\n\u003cth\u003eConcentration Basis\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSkilled Nursing\/Transitional Care\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e217\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAnnualized Cash NOI\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSenior Housing – Managed\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e83\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAnnualized Cash NOI\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSenior Housing – Leased\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e32\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAnnualized Cash NOI\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBehavioral Health\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e16\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAnnualized Cash NOI\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty Hospitals and Other\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e15\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAnnualized Cash NOI\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe portfolio composition, based on property count, reflects the diversification strategy:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSkilled Nursing\/Transitional Care: \u003cstrong\u003e217\u003c\/strong\u003e properties\u003c\/li\u003e\n\u003cli\u003eSenior Housing – Managed: \u003cstrong\u003e83\u003c\/strong\u003e properties\u003c\/li\u003e\n\u003cli\u003eSenior Housing – Leased: \u003cstrong\u003e32\u003c\/strong\u003e properties\u003c\/li\u003e\n\u003cli\u003eBehavioral Health: \u003cstrong\u003e16\u003c\/strong\u003e properties\u003c\/li\u003e\n\u003cli\u003eSpecialty Hospitals and Other: \u003cstrong\u003e15\u003c\/strong\u003e properties\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eSabra Health Care REIT, Inc. (SBRA) - VRIO Analysis: 4. Portfolio Concentration in Needs-Based Assets\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Ensures long-term demand driven by unavoidable demographic trends, like the \u003cstrong\u003e85 and older population\u003c\/strong\u003e projected to increase from \u003cstrong\u003e6.5 million in 2022 to 13.7 million in 2040\u003c\/strong\u003e (a \u003cstrong\u003e111%\u003c\/strong\u003e increase) in the U.S.. The \u003cstrong\u003e65 and older population\u003c\/strong\u003e is projected to rise from \u003cstrong\u003e58 million in 2022 to 82 million by 2050\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e While all healthcare REITs target this, Sabra’s specific mix - with Skilled Nursing\/Transitional Care at nearly \u003cstrong\u003e49%\u003c\/strong\u003e of NOI - is a specific bet.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Low. Competitors have different historical portfolio compositions they cannot easily change without massive, costly sales.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e The organization is built around underwriting and managing these specific asset types, from SNF to Behavioral Health.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Sustained. Demographic reality provides a long-term moat.\u003c\/p\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eAsset Class\u003c\/th\u003e\n\u003cth\u003eProperties (as of 09\/30\/2025)\u003c\/th\u003e\n\u003cth\u003eApproximate % of Annualized Cash NOI\u003c\/th\u003e\n\u003cth\u003eQ3 2025 EBITDARM Coverage\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSkilled Nursing\/Transitional Care\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e217\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e48%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e2.35x\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSenior Housing – Managed\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e83\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e25.9%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eN\/A (SS Cash NOI Growth YoY: \u003cstrong\u003e13.3%\u003c\/strong\u003e)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSenior Housing – Leased\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e32\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e7.8%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e1.52x\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eBehavioral Health\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e16\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e13.1%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e3.90x\u003c\/strong\u003e (Behavioral Health, Specialty Hospitals and Other)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSpecialty Hospital and Other\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e15\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e3.7%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e3.90x\u003c\/strong\u003e (Behavioral Health, Specialty Hospitals and Other)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganizational Structure \u0026amp; Performance Metrics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eTotal Real Estate Properties Held for Investment: \u003cstrong\u003e363\u003c\/strong\u003e as of September 30, 2025.\u003c\/li\u003e\n\u003cli\u003eQ3 2025 Normalized FFO per diluted common share: \u003cstrong\u003e$0.36\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eQ3 2025 Normalized AFFO per diluted common share: \u003cstrong\u003e$0.38\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eManaged Senior Housing Same Store Cash NOI increased \u003cstrong\u003e13.3%\u003c\/strong\u003e year-over-year in Q3 2025.\u003c\/li\u003e\n\u003cli\u003eThe organization is updating its managed senior housing target concentration from \u003cstrong\u003e30% to 40%\u003c\/strong\u003e of total NOI due to faster-than-anticipated growth.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eSabra Health Care REIT, Inc. (SBRA) - VRIO Analysis: 5. Active Capital Recycling Program\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Allows Sabra to shed mature or underperforming assets and redeploy capital into higher-yielding, newer vintage properties, boosting overall portfolio quality.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Many REITs are slow to sell; Sabra actively evaluates and recycles capital from mature assets.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Moderately difficult; it requires the organizational discipline to sell assets even when the market is uncertain.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e They demonstrated this by disposing of assets and redeploying capital.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary. It’s an execution skill that can be copied by disciplined management teams.\u003c\/p\u003e\n\u003cp\u003eThe active capital recycling strategy is supported by ongoing transaction activity and balance sheet management:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNet Debt to Adjusted EBITDA was reported at \u003cstrong\u003e4.96x\u003c\/strong\u003e as of September 30, 2025.\u003c\/li\u003e\n\u003cli\u003eAs of March 31, 2025, Net Debt to Adjusted EBITDA improved to \u003cstrong\u003e5.19x\u003c\/strong\u003e, attributed to NOI growth, capital recycling, and ATM program use.\u003c\/li\u003e\n\u003cli\u003eThe portfolio composition as of March 31, 2025, included \u003cstrong\u003e399\u003c\/strong\u003e investments across \u003cstrong\u003e59\u003c\/strong\u003e relationships, with Skilled Nursing\/Transitional Care at \u003cstrong\u003e51.6%\u003c\/strong\u003e and Senior Housing-Managed at \u003cstrong\u003e19.6%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eIn 2024, Sabra recognized an aggregate net gain of \u003cstrong\u003e$2.1 million\u003c\/strong\u003e related to the disposition of \u003cstrong\u003e17\u003c\/strong\u003e skilled nursing\/transitional care facilities and \u003cstrong\u003eone\u003c\/strong\u003e behavioral health facility.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe execution of the capital recycling program is evidenced by the following recent transaction metrics:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003ePeriod\/Date\u003c\/td\u003e\n\u003ctd\u003eAmount\/Count\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eManaged Senior Housing Acquisitions Closed\u003c\/td\u003e\n\u003ctd\u003eThird Quarter of 2025\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e6\u003c\/strong\u003e properties for \u003cstrong\u003e$217.5 million\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEstimated Initial Cash Yield on Q3 2025 Acquisitions\u003c\/td\u003e\n\u003ctd\u003eThird Quarter of 2025\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e7.8%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAdditional Managed Senior Housing Acquisitions Closed (Post Q3)\u003c\/td\u003e\n\u003ctd\u003eSubsequent to Q3 2025\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003e3\u003c\/strong\u003e properties for \u003cstrong\u003e$124.0 million\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Investments Closed Year-to-Date\u003c\/td\u003e\n\u003ctd\u003eAs of Q3 2025 End\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$421.9 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eForward Sale Agreements Settlement Proceeds\u003c\/td\u003e\n\u003ctd\u003eThird Quarter of 2025\u003c\/td\u003e\n\u003ctd\u003eNet proceeds of \u003cstrong\u003e$165.0 million\u003c\/strong\u003e (from \u003cstrong\u003e9.6 million\u003c\/strong\u003e shares)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNew ATM Program Size Established\u003c\/td\u003e\n\u003ctd\u003eAugust 5, 2025\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$750 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp\u003eThe discipline required for this program is reflected in the strategic use of equity issuance to fund growth:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eDuring Q1 2025, \u003cstrong\u003e$84.3 million\u003c\/strong\u003e was issued on a forward basis at an average price of \u003cstrong\u003e$17.32\u003c\/strong\u003e per share.\u003c\/li\u003e\n\u003cli\u003eIn Q3 2025, \u003cstrong\u003e9.6 million\u003c\/strong\u003e shares were issued in settlement of outstanding forward sale agreements at a weighted average price of \u003cstrong\u003e$17.26\u003c\/strong\u003e per share, net of commissions.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eSabra Health Care REIT, Inc. (SBRA) - VRIO Analysis: 6. Strong Tenant Financial Health Metrics\n\u003c\/h2\u003e\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e High coverage ratios signal that tenants can comfortably cover their rent obligations, reducing near-term default risk. SNF\/TC coverage was \u003cstrong\u003e2.35x\u003c\/strong\u003e in Q3 2025.\u003c\/p\u003e\n\u003cp\u003e\n\u003c\/p\u003e\u003ctable\u003e\n    \u003cthead\u003e\n        \u003ctr\u003e\n            \u003cth\u003eAsset Class\u003c\/th\u003e\n            \u003cth\u003eEBITDARM Coverage (Q3 2025)\u003c\/th\u003e\n            \u003cth\u003ePortfolio Weight (Approx. % of Portfolio)\u003c\/th\u003e\n        \u003c\/tr\u003e\n    \u003c\/thead\u003e\n    \u003ctbody\u003e\n        \u003ctr\u003e\n            \u003ctd\u003eSkilled Nursing\/Transitional Care (SNF\/TC)\u003c\/td\u003e\n            \u003ctd\u003e\u003cstrong\u003e2.35x\u003c\/strong\u003e\u003c\/td\u003e\n            \u003ctd\u003e\u003cstrong\u003e48.9%\u003c\/strong\u003e\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n            \u003ctd\u003eSenior Housing - Leased (SH-Leased)\u003c\/td\u003e\n            \u003ctd\u003e\u003cstrong\u003e1.52x\u003c\/strong\u003e\u003c\/td\u003e\n            \u003ctd\u003e\u003cstrong\u003e7.8%\u003c\/strong\u003e\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n            \u003ctd\u003eBehavioral Health, Specialty Hospitals and Other (BH\/Hosp\/Oth)\u003c\/td\u003e\n            \u003ctd\u003e\u003cstrong\u003e3.90x\u003c\/strong\u003e\u003c\/td\u003e\n            \u003ctd\u003e\n\u003cstrong\u003e24.2%\u003c\/strong\u003e (BH 13.1% + Other 11.1% approx.)\u003c\/td\u003e\n        \u003c\/tr\u003e\n        \u003ctr\u003e\n            \u003ctd\u003eSenior Housing - Managed (SH-Managed)\u003c\/td\u003e\n            \u003ctd\u003eN\/A (Cash NOI metric)\u003c\/td\u003e\n            \u003ctd\u003e\u003cstrong\u003e25.9%\u003c\/strong\u003e\u003c\/td\u003e\n        \u003c\/tr\u003e\n    \u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Achieving these specific ratios across a diversified portfolio in the current environment is a sign of quality underwriting. Same store managed senior housing Cash NOI increased \u003cstrong\u003e13.3%\u003c\/strong\u003e year-over-year in Q3 2025.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Difficult; it reflects the quality of the operators they choose, which is tied to their relationship strategy. Portfolio consisted of \u003cstrong\u003e397\u003c\/strong\u003e investments across \u003cstrong\u003e60\u003c\/strong\u003e relationships as of September 30, 2025.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e Management uses these metrics, like EBITDARM Coverage, as a primary tool for ongoing operator assessment. Key balance sheet metrics monitored include Net Debt to Adjusted EBITDA, which was \u003cstrong\u003e4.96x\u003c\/strong\u003e as of September 30, 2025.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary. Tenant health can fluctuate with economic and reimbursement changes. Sabra acquired six managed senior housing properties in Q3 2025 for \u003cstrong\u003e$217.5 million\u003c\/strong\u003e with an estimated initial cash yield of \u003cstrong\u003e7.8%\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cul\u003e\n    \u003cli\u003ePortfolio coverage for top ten tenants showed its best showing yet in Q3 2025.\u003c\/li\u003e\n    \u003cli\u003eSame store managed senior housing Cash NOI growth was \u003cstrong\u003e15.9%\u003c\/strong\u003e year-over-year, excluding 16 former Holiday properties.\u003c\/li\u003e\n    \u003cli\u003eSabra declared a quarterly cash dividend of \u003cstrong\u003e$0.30\u003c\/strong\u003e per share in November 2025.\u003c\/li\u003e\n    \u003cli\u003eThis dividend represented a payout of \u003cstrong\u003e79%\u003c\/strong\u003e of Q3 normalized AFFO per share.\u003c\/li\u003e\n    \u003cli\u003eLiquidity as of September 30, 2025, was approximately \u003cstrong\u003e$1.1 billion\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eSabra Health Care REIT, Inc. (SBRA) - VRIO Analysis: 7. Significant Available Liquidity\n\u003c\/h2\u003e\n\u003cp\u003e\nValue: Provides dry powder for opportunistic acquisitions and the ability to fund capital expenditures without immediate, dilutive equity raises. They had \u003cstrong\u003e$1.1 billion\u003c\/strong\u003e in liquidity as of September 30, 2025.\n\u003c\/p\u003e\n\u003cp\u003e\nThe total liquidity of \u003cstrong\u003e$1.1 billion\u003c\/strong\u003e as of September 30, 2025, was composed of:\n\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eUnrestricted cash and cash equivalents: \u003cstrong\u003e$200.6 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eAvailable borrowings under the revolving credit facility: \u003cstrong\u003e$717.8 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eProceeds related to shares outstanding under forward sale agreements (ATM program): \u003cstrong\u003e$157.3 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\nThe company also had \u003cstrong\u003e$690.9 million\u003c\/strong\u003e available under the ATM program as of September 30, 2025.\n\u003c\/p\u003e\n\u003cp\u003e\nRarity: Having over a billion in liquidity while maintaining a strong credit rating is a powerful position, especially when competitors might be constrained. Moody's Ratings upgraded Sabra's senior unsecured notes rating to “\u003cstrong\u003eBaa3\u003c\/strong\u003e” from “Ba1” and assigned a “\u003cstrong\u003eBaa3\u003c\/strong\u003e” issuer rating with a Stable outlook on September 10, 2025. As of September 30, 2025, Net Debt to Adjusted EBITDA was \u003cstrong\u003e4.96x\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cp\u003e\nImitability: Moderately difficult; it requires consistent use of equity programs like the ATM program to build up cash reserves. During the third quarter of 2025, Sabra issued \u003cstrong\u003e9.6 million\u003c\/strong\u003e shares in settlement of outstanding forward sale agreements at a weighted average price of \u003cstrong\u003e$17.26\u003c\/strong\u003e per share, net of commissions, resulting in net proceeds of \u003cstrong\u003e$165.0 million\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cp\u003e\nOrganization: The company is organized to deploy this, noting they expect to use proceeds from forward contracts to close awarded investments. Sabra has been awarded approximately \u003cstrong\u003e$120 million\u003c\/strong\u003e of additional senior housing investments with an estimated initial cash yield of nearly \u003cstrong\u003e8%\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cp\u003e\nCompetitive Advantage: Temporary. Liquidity levels change quarter-to-quarter based on deployment and financing.\n\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eAmount \/ Rating\u003c\/th\u003e\n\u003cth\u003eDate\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotal Liquidity\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$1.1 billion\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSeptember 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUnrestricted Cash \u0026amp; Cash Equivalents\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$200.6 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSeptember 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAvailable Revolving Credit Borrowings\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$717.8 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSeptember 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMoody's Issuer Rating\u003c\/td\u003e\n\u003ctd\u003e\n\u003cstrong\u003eBaa3\u003c\/strong\u003e (Stable Outlook)\u003c\/td\u003e\n\u003ctd\u003eSeptember 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet Debt to Adjusted EBITDA\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e4.96x\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eSeptember 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAwarded Investments Pipeline\u003c\/td\u003e\n\u003ctd\u003eApprox. \u003cstrong\u003e$120 million\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eQ3 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cbr\u003e\u003ch2\u003eSabra Health Care REIT, Inc. (SBRA) - VRIO Analysis: 8. Favorable Reimbursement Environment Alignment\n\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Direct exposure to rising government payor rates, which directly flows through to tenant profitability and rent coverage, especially in the SNF segment.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e Sabra’s specific weighting in SNF\/TC gives it outsized benefit from the finalized \u003cstrong\u003e3.2%\u003c\/strong\u003e Medicare increase and estimated \u003cstrong\u003e5%\u003c\/strong\u003e Medicaid increase in key states.\u003c\/p\u003e\n\n\u003cp\u003eThe impact of these external reimbursement changes is magnified by Sabra’s portfolio composition:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSkilled nursing and transitional care facilities represented \u003cstrong\u003e51.6%\u003c\/strong\u003e of Sabra's portfolio as of March 31, 2025.\u003c\/li\u003e\n\u003cli\u003eFor the year ended December 31, 2024, \u003cstrong\u003e39.2%\u003c\/strong\u003e of Sabra's revenues was derived directly or indirectly from skilled nursing\/transitional care facilities.\u003c\/li\u003e\n\u003cli\u003eAs of September 30, 2025, EBITDARM rent coverage for the Skilled Nursing\/Transitional Care segment stood at \u003cstrong\u003e2.35x\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eThe Centers for Medicare \u0026amp; Medicaid Services (CMS) finalized a \u003cstrong\u003e3.2%\u003c\/strong\u003e Medicare rate increase effective October 1, 2025.\u003c\/li\u003e\n\u003cli\u003eHistorically, Medicaid rates for Sabra's SNF portfolio have increased from \u003cstrong\u003e$179\u003c\/strong\u003e in January 2012 to \u003cstrong\u003e$309\u003c\/strong\u003e in January 2025, representing a \u003cstrong\u003e4.2%\u003c\/strong\u003e CAGR.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue \/ Rate\u003c\/th\u003e\n\u003cth\u003eDate \/ Context\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSNF\/TC Investment % of Portfolio\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e51.6%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAs of March 31, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSNF\/TC Revenue % of Total\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e39.2%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFor the year ended December 31, 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSNF EBITDARM Rent Coverage\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e2.35x\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eAs of September 30, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFinalized Medicare Rate Increase\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e3.2%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eEffective October 1, 2025\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFY 2025 Net Medicare Rate Increase (Aggregate)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e4.2%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eFY 2025 Final Rule\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEstimated Medicaid Increase (Key States)\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e5%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003eStated in analysis premise\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Low. This is an external factor, but Sabra’s portfolio weighting is a deliberate, hard-to-change structural choice.\u003c\/p\u003e\n\u003cp\u003eThe portfolio composition reflects a long-term strategic decision:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSabra's portfolio included \u003cstrong\u003e217\u003c\/strong\u003e skilled nursing\/transitional care facilities as of September 30, 2025.\u003c\/li\u003e\n\u003cli\u003eThe overall portfolio consists of \u003cstrong\u003e399\u003c\/strong\u003e investments across \u003cstrong\u003e59\u003c\/strong\u003e relationships as of March 31, 2025.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e Management actively tracks and highlights these rate changes as a key driver for future coverage improvement.\u003c\/p\u003e\n\u003cp\u003eManagement commentary confirms the focus on these drivers:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eEBITDARM rent coverage for the triple-net portfolio hit another post-pandemic high during the third quarter of 2025.\u003c\/li\u003e\n\u003cli\u003e2025 Normalized FFO guidance range is \u003cstrong\u003e$1.45 - $1.47\u003c\/strong\u003e per diluted common share, assuming low-single-digit Cash NOI growth for the triple-net portfolio.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Temporary. Reimbursement policy is subject to political change, though the aging trend suggests long-term support.\u003c\/p\u003e\n\u003cp\u003eThe underlying demographic trend provides a secular tailwind:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eSince the year 2000, the 85+ aged population has grown by \u003cstrong\u003e60%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eOver the same period, the number of SNF beds has declined by \u003cstrong\u003e12%\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cbr\u003e\u003ch2\u003eSabra Health Care REIT, Inc. (SBRA) - VRIO Analysis: 9. Disciplined, Balance-Oriented Acquisition Strategy\n\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eValue:\u003c\/strong\u003e Prevents overpaying for assets or becoming too concentrated in one area, ensuring accretive growth that supports the dividend. They focus on deals under \u003cstrong\u003e$100 million\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eRarity:\u003c\/strong\u003e In a market where large portfolio deals can be tempting, sticking to smaller, balance-enhancing acquisitions shows rare discipline.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eImitability:\u003c\/strong\u003e Difficult; this is a cultural trait rooted in management’s risk appetite and decision-making process.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOrganization:\u003c\/strong\u003e The organization enforces this by prioritizing portfolio balance over simply chasing the largest deal available.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCompetitive Advantage:\u003c\/strong\u003e Sustained. This discipline, if maintained, becomes a core part of the firm’s DNA.\u003c\/p\u003e\n\n\u003cp\u003eThe organization's discipline is evidenced by recent transaction profiles and overall portfolio health metrics:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePortfolio consisted of \u003cstrong\u003e399 investments\u003c\/strong\u003e across \u003cstrong\u003e59 relationships\u003c\/strong\u003e as of March 31, 2025.\u003c\/li\u003e\n\u003cli\u003eNet Debt to Adjusted EBITDA was \u003cstrong\u003e4.96x\u003c\/strong\u003e as of September 30, 2025.\u003c\/li\u003e\n\u003cli\u003eThe quarterly cash dividend declared in Q3 2025 was \u003cstrong\u003e$0.30\u003c\/strong\u003e per share of common stock.\u003c\/li\u003e\n\u003cli\u003eThe strategy targets deals that enhance balance, exemplified by the Q3 2025 acquisition of six managed senior housing properties for \u003cstrong\u003e$217.5 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe following table illustrates the application of the stated yield focus in actual and hypothetical transactions:\u003c\/p\u003e\n\u003ctable\u003e\n\u003cthead\u003e\n\u003ctr\u003e\n\u003ctd\u003eMetric\u003c\/td\u003e\n\u003ctd\u003eActual Q3 2025 Acquisition (6 Properties)\u003c\/td\u003e\n\u003ctd\u003eHypothetical $100 Million Acquisition\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eInvestment Amount\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$217.5 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e$100 million\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEstimated Initial Cash Yield\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e7.8%\u003c\/strong\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cstrong\u003e7.8%\u003c\/strong\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAsset Type Focus\u003c\/td\u003e\n\u003ctd\u003eManaged Senior Housing\u003c\/td\u003e\n\u003ctd\u003eBalance-Oriented (Implied)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePro-Forma Impact on NFFO\/Share (Q3 2025)\u003c\/td\u003e\n\u003ctd\u003eIncluded in reported \u003cstrong\u003e$0.36\u003c\/strong\u003e\n\u003c\/td\u003e\n\u003ctd\u003eIncrease of approximately \u003cstrong\u003e$0.0118\u003c\/strong\u003e per share\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\n\u003cp\u003e\u003cstrong\u003eFinance:\u003c\/strong\u003e Pro-forma impact of a \u003cstrong\u003e$100 million\u003c\/strong\u003e acquisition at a \u003cstrong\u003e7.8%\u003c\/strong\u003e yield on Q3 2025 Normalized FFO:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eQ3 2025 Total Normalized FFO: \u003cstrong\u003e$88.6 million\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eQ3 2025 Diluted Common Shares Outstanding: \u003cstrong\u003e243,558,449\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eAnnualized Cash Flow from Acquisition: $100,000,000 \\times 7.8\\% = \u003cstrong\u003e$7,800,000\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003eQuarterly Cash Flow Impact: $7,800,000 \/ 4 = \u003cstrong\u003e$1,950,000\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003ePro-Forma Q3 2025 Normalized FFO: $88,600,000 + $1,950,000 = \u003cstrong\u003e$90,550,000\u003c\/strong\u003e.\u003c\/li\u003e\n\u003cli\u003ePro-Forma Q3 2025 Normalized FFO per Share: $90,550,000 \/ 243,558,449 \\approx \u003cstrong\u003e$0.3718\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"dcf.fm","offers":[{"title":"Default Title","offer_id":45516246745237,"sku":"sbra-vrio-analysis","price":7.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0630\/5189\/0837\/files\/sbra-vrio-analysis.png?v=1740212550","url":"https:\/\/dcf-model.com\/fr\/products\/sbra-vrio-analysis","provider":"AI-Powered Discounted Cash Flow Model Templates","version":"1.0","type":"link"}